Cartalax (20 mg)

Cartalax, a concise peptide possessing bioregulatory characteristics, primarily influences fibroblasts, pervasive cells present in diverse tissues ranging from cartilage to skin, blood vessels, and the kidneys. Studies suggest that Cartalax modulates cell proliferation and apoptosis via multiple molecular pathways, such as elevating Ki-67 levels, diminishing p53 signaling, and triggering NF-KB signaling. Categorized as an anti-aging bioregulator, Cartalax diminishes senescence, rejuvenates older cells, and seemingly decelerates the general aging process within tissues.